IMMX logo
IMMX NASDAQ US

Immix Biopharma, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2021
$8.94
▲ +$0.32 (+3.71%)
Vol 418K
2
Quality Score
fail
Mkt Cap
$275.6M
ROE
-263.6%
D/E
0.00
Beta
0.31
52W
$1–$8

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Similar Stocks

TRDA
Entrada Therapeutics Inc
$392.9M
VSTM
Verastem Inc
$581.5M
LYEL
Lyell Immunopharma Inc
$653.9M
FDMT
4D Molecular Therapeutics Inc
$428.5M
ABSI
Absci Corp
$524.8M
ASMB
Assembly Biosciences Inc
$537.9M
STTK
Shattuck Labs Inc
$231.0M
MYGN
Myriad Genetics Inc
$573.3M
RGNX
Regenxbio Inc
$729.0M

Earnings

Beat rate: 40.0%
Next Report May 06, 2026
EPS Estimate: $-0.21
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.21 — —
Dec 2025 $-0.16 $-0.28 $-0.12
Sep 2025 $-0.19 $-0.24 $-0.05
Jun 2025 $-0.16 $-0.22 $-0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -205.4% -205.4% -205.4% -205.4% -205.4% -263.6%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.23 1.23 1.23 1.23 1.23 1.53

Key Ratios

ROA (TTM)
-120.0%
P/B
4.6
EPS (TTM)
$-0.77
CF/Share
$-0.93
52W High
$7.73
52W Low
$1.34
$1.34 52-Week Range $7.73

How does IMMX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

IMMX AAPG ABEO ABOS ABP

IMMX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.6
▲ 86% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

IMMX profitability vs Biotechnology peers

ROE
-263.6%
▼ 292% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-120.0%
▼ 157% below peers (-46.7%)
vs Peers
vs Industry
Weak

IMMX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.5
▼ 66% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼ 68% below peers (1.0)
vs Peers
vs Industry
More volatile

IMMX fundamentals radar

IMMX Peer median Industry

IMMX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IMMX vs peers: key metrics

Latest News

No related news yet